These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15727138)

  • 1. [Tetracyclines: progress of fundamental research].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2004; 49(8-9):4-7. PubMed ID: 15727138
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.
    Rasmussen BA; Gluzman Y; Tally FP
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1658-60. PubMed ID: 7526784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacterial resistance mechanisms for tetracyclines].
    Yamaguchi A
    Nihon Rinsho; 1997 May; 55(5):1245-51. PubMed ID: 9155182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes.
    Nonaka L; Connell SR; Taylor DE
    J Bacteriol; 2005 Jun; 187(11):3708-12. PubMed ID: 15901694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical biology of tetracycline antibiotics.
    Zakeri B; Wright GD
    Biochem Cell Biol; 2008 Apr; 86(2):124-36. PubMed ID: 18443626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome.
    Rasmussen B; Noller HF; Daubresse G; Oliva B; Misulovin Z; Rothstein DM; Ellestad GA; Gluzman Y; Tally FP; Chopra I
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2306-11. PubMed ID: 1725100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Future development of antibiotics. 4. Tetracycline antibiotics].
    Goto S; Nishida M
    Nihon Rinsho; 1984 Mar; 42(3):547-52. PubMed ID: 6433077
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemistry. A new route to designer antibiotics.
    Khosla C; Tang Y
    Science; 2005 Apr; 308(5720):367-8. PubMed ID: 15831747
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.
    Nelson ML; Park BH; Andrews JS; Georgian VA; Thomas RC; Levy SB
    J Med Chem; 1993 Feb; 36(3):370-7. PubMed ID: 8426364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracyclines: antibiotic action, uptake, and resistance mechanisms.
    Schnappinger D; Hillen W
    Arch Microbiol; 1996 Jun; 165(6):359-69. PubMed ID: 8661929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protection proteins and their mechanism of tetracycline resistance.
    Connell SR; Tracz DM; Nierhaus KH; Taylor DE
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3675-81. PubMed ID: 14638464
    [No Abstract]   [Full Text] [Related]  

  • 12. Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule.
    Chopra I
    J Antimicrob Chemother; 1986 Dec; 18(6):661-6. PubMed ID: 3546242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures.
    Mortison JD; Schenone M; Myers JA; Zhang Z; Chen L; Ciarlo C; Comer E; Natchiar SK; Carr SA; Klaholz BP; Myers AG
    Cell Chem Biol; 2018 Dec; 25(12):1506-1518.e13. PubMed ID: 30318461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracycline analogs whose primary target is not the bacterial ribosome.
    Chopra I
    Antimicrob Agents Chemother; 1994 Apr; 38(4):637-40. PubMed ID: 8031024
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
    Clark RB; Hunt DK; He M; Achorn C; Chen CL; Deng Y; Fyfe C; Grossman TH; Hogan PC; O'Brien WJ; Plamondon L; Rönn M; Sutcliffe JA; Zhu Z; Xiao XY
    J Med Chem; 2012 Jan; 55(2):606-22. PubMed ID: 22148555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycylcyclines: a new generation of tetracyclines.
    Tally FT; Ellestad GA; Testa RT
    J Antimicrob Chemother; 1995 Apr; 35(4):449-52. PubMed ID: 7628979
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
    Xiao XY; Hunt DK; Zhou J; Clark RB; Dunwoody N; Fyfe C; Grossman TH; O'Brien WJ; Plamondon L; Rönn M; Sun C; Zhang WY; Sutcliffe JA
    J Med Chem; 2012 Jan; 55(2):597-605. PubMed ID: 22148514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 1: tetracyclines.
    Barza M; Schiefe RT
    Am J Hosp Pharm; 1977 Jan; 34(1):49-57. PubMed ID: 318799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial and inducer activities for tetracycline resistance by its derivates and analogues.
    Inoue M; Kazawa T; Mitsuhashi S
    Microbiol Immunol; 1977; 21(2):59-67. PubMed ID: 870795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 9-substituted tetracycline derivatives.
    Koza DJ; Nsiah YA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2163-5. PubMed ID: 12127528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.